Balanced news tone
News Sentiment
PBLS sentiment intelligence
Parabilis Medicines, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
52 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+2.7% over one week, - over four weeks, trend inactive, and near fair-value range.
PBLS Stock: Price, Forecast, Financials & AI Analysis
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
2.7%
Price confirming higher
Trend fit
Trend inactive
Weekly context
Fair value
6.1%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
15
Neutral
34
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Intellectia AI
Direct company coverage
PBLS Stock: Price, Forecast, Financials & AI Analysis
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 07 Jul 2026 10:35
- Source
- Intellectia AI
Moomoo
Direct company coverage
Leerink Partners Initiates Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $40
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 06 Jul 2026 20:17
- Source
- Moomoo
Stocktwits
Direct company coverage
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 14:35
- Source
- Stocktwits
Benzinga
Direct company coverage
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 06 Jul 2026 11:11
- Source
- Benzinga
Investing.com UK
Direct company coverage
Guggenheim initiates Parabilis Medicines stock with buy rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 06 Jul 2026 07:51
- Source
- Investing.com UK
timothysykes.com
Direct company coverage
Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Jul 2026 15:08
- Source
- timothysykes.com
StocksToTrade
Direct company coverage
Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 00:53
- Source
- StocksToTrade
TradingView
Direct company coverage
Why Tenet Healthcare (THC) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 15:31
- Source
- TradingView
Quiver Quantitative
Direct company coverage
Insider Stock Purchases: June 29, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 18:45
- Source
- Quiver Quantitative
Stock Titan
Direct company coverage
[Form 4] Parabilis Medicines, Inc. Insider Trading Activity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 14:41
- Source
- Stock Titan
Stock Titan
Direct company coverage
Parabilis Medicines (PBLS) holder reports 527,070-share Series F position
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 14:38
- Source
- Stock Titan
The Motley Fool
Direct company coverage
Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- The Motley Fool
Stock Titan
Direct company coverage
[SCHEDULE 13D] Parabilis Medicines, Inc. Major Shareholder Acquisition (>5%)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Apothecary Capital, tied to Parabilis (PBLS) director, buys 17,500 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Parabilis (PBLS) director-linked LLC makes open-market buy of 12,500 shares
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
RA Capital funds lift Parabilis Medicines (PBLS) common equity exposure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Parabilis Medicines (PBLS) director converts preferred stock into common around IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Parabilis Medicines (PBLS) director converts Series F preferred into common in IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Parabilis Medicines (PBLS) director granted 20,215 options at $20.00 strike
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Parabilis Medicines (PBLS) director receives stock options for 20,215 shares at $20
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Stock Titan
MT Newswires
Direct company coverage
Parabilis Medicines Closes Initial Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 20:36
- Source
- MT Newswires
Stock Titan
Direct company coverage
Biotech Parabilis raises over $1.2B in 2026, backed by Regeneron
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Market source
Barchart
Direct company coverage
How to Play PBLS Stock After the Parabilis IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Barchart
Pharmaceutical Executive
Direct company coverage
Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Pharmaceutical Executive
Stock Titan
Direct company coverage
PARABILIS MEDICINES (PBLS) Stock News & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
PARABILIS MEDICINES (PBLS) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Stock Titan
MT Newswires
Direct company coverage
Parabilis Medicines to Raise $745 Million in IPO, Private Offering
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 10 Jun 2026 10:03
- Source
- MT Newswires